GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Patterson Companies Inc (NAS:PDCO) » Definitions » EBIT

Patterson (Patterson) EBIT

: $298 Mil (TTM As of Jan. 2024)
View and export this data going back to 1992. Start your Free Trial

Patterson's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2024 was $74 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was $298 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Patterson's annualized ROC % for the quarter that ended in Jan. 2024 was 11.44%. Patterson's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 26.66%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Patterson's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 9.59%.


Patterson EBIT Historical Data

The historical data trend for Patterson's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Patterson Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.89 -548.62 224.22 286.54 303.80

Patterson Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.02 109.86 50.12 64.00 73.67

Competitive Comparison

For the Medical Distribution subindustry, Patterson's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Patterson EV-to-EBIT Distribution

For the Medical Distribution industry and Healthcare sector, Patterson's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Patterson's EV-to-EBIT falls into.



Patterson EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $298 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Patterson  (NAS:PDCO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Patterson's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=280.048 * ( 1 - 23.16% )/( (1863.394 + 1898.5)/ 2 )
=215.1888832/1880.947
=11.44 %

where

Invested Capital(Q: Oct. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2889.69 - 912.41 - ( 113.886 - max(0, 1148.542 - 1790.676+113.886))
=1863.394

Invested Capital(Q: Jan. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2939.949 - 917.451 - ( 123.998 - max(0, 1283.713 - 1832.563+123.998))
=1898.5

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Patterson's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=294.66/( ( (320.509 + max(764.38, 0)) + (334.519 + max(791.114, 0)) )/ 2 )
=294.66/( ( 1084.889 + 1125.633 )/ 2 )
=294.66/1105.261
=26.66 %

where Working Capital is:

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(490.428 + 858.028 + 328.334) - (912.41 + 0 + 0)
=764.38

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(484.53 + 902.733 + 321.302) - (917.451 + 0 + 0)
=791.114

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Patterson's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2024 )
=297.644/3103.062
=9.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Patterson EBIT Related Terms

Thank you for viewing the detailed overview of Patterson's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Patterson (Patterson) Business Description

Traded in Other Exchanges
Address
1031 Mendota Heights Road, Saint Paul, MN, USA, 55120
Patterson Companies Inc is a leading dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives a majority of its revenue from the United States.
Executives
Kevin Michael Barry officer: Chief Financial Officer 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Donald Zurbay officer: Chief Financial Officer C/O ST. JUDE MEDICAL, INC., ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN 55117
Timothy E Rogan officer: President - Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Les B Korsh officer: VP, General Counsel 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55110
Meenu Agarwal director 7246 E MERCER WAY, MERCER ISLAND WA 98040
Samantha L Bergeson officer: CHRO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Andrea L. Frohning officer: Chief Human Resources Officer C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Philip Mckoy director 120 BROADWAY, SUITE 200, SANTA MONICA CA 90401
Jody H Feragen director 1 HORMEL PLACE, AUSTIN TX 55912
Eric R Shirley officer: President-Patterson Dental 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Francis Joseph Malecha director 9900 WEST 109TH STREET, SUITE 100, OVERLAND PARK KS 66210
Robert Frenzel director 414 NICOLLET MALL, MINNEAPOLIS MN 55401
Dennis W Goedken officer: Interim CFO 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
Ann B Gugino officer: Vice President 1031 MENDOTA HEIGHTS ROAD, ST. PAUL MN 55120
John D Buck director 4201 GULF SHORE BLVD NORTH, APT 1703N, NAPLES FL 34103